BDIV |
ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time |
N-ethyl-N-nitrosourea (80 mg/kg) |
van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. |
life span trait |
female |
200 days
| 49 |
|
|
100.0 |
% |
|
|
in vivo visual assessment |
0.0 |
ENU injection |
200 |
days |
PI time in S1 |
ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873) |
98172 |
2018 |
BDIV |
percentage of study population displaying trigeminal nerve neurilemmomas at a point in time |
N-ethyl-N-nitrosourea (80 ug/g) |
van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. |
trigeminal nerve integrity trait |
female |
200 days
| 49 |
|
|
0.0 |
% |
|
|
in vivo visual assessment |
0.0 |
|
0 |
|
inferred from Kaplan-Meier plot analysis |
|
98156 |
2018 |
BDIV |
ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time |
N-ethyl-N-nitrosourea (80 mg/kg) |
van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. |
life span trait |
both |
200 days
| 112 |
|
|
100.0 |
% |
|
|
in vivo visual assessment |
0.0 |
ENU injection |
200 |
days |
PI time in S1 |
ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873) |
98173 |
2018 |
BDIV |
ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time |
N-ethyl-N-nitrosourea (80 mg/kg) |
van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. |
life span trait |
male |
200 days
| 63 |
|
|
100.0 |
% |
|
|
in vivo visual assessment |
0.0 |
ENU injection |
200 |
days |
PI time in S1 |
ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873) |
98171 |
2018 |
BDIV |
post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors |
N-ethyl-N-nitrosourea (80 mg/kg) |
van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. |
life span trait |
male |
0 days
| 63 |
Kaplan Meier estimate |
median |
593.0 |
d |
|
|
necropsy |
0.0 |
|
0 |
|
|
|
98139 |
2018 |
BDIV |
post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors |
N-ethyl-N-nitrosourea (80 mg/kg) |
van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. |
life span trait |
both |
0 days
| 112 |
Kaplan Meier estimate |
median |
593.0 |
d |
|
|
necropsy |
0.0 |
|
0 |
|
|
|
98141 |
2018 |
BDIV |
percentage of study population displaying trigeminal nerve neurilemmomas at a point in time |
N-ethyl-N-nitrosourea (80 ug/g) |
van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. |
trigeminal nerve integrity trait |
male |
200 days
| 63 |
|
|
0.0 |
% |
|
|
in vivo visual assessment |
0.0 |
|
0 |
|
inferred from Kaplan-Meier plot analysis |
|
98155 |
2018 |
BDIV |
post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors |
N-ethyl-N-nitrosourea (80 mg/kg) |
van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. |
life span trait |
female |
0 days
| 49 |
Kaplan Meier estimate |
median |
482.0 |
d |
|
|
necropsy |
0.0 |
|
0 |
|
|
|
98140 |
2018 |
BDIV |
percentage of study population displaying trigeminal nerve neurilemmomas at a point in time |
N-ethyl-N-nitrosourea (80 ug/g) |
van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. |
trigeminal nerve integrity trait |
both |
200 days
| 112 |
|
|
0.0 |
% |
|
|
in vivo visual assessment |
0.0 |
|
0 |
|
inferred from Kaplan-Meier plot analysis |
|
98157 |
2018 |